# Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).

> **NCT00716820** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 472 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** SUNITINIB MALATE

## Key facts

- **NCT ID:** NCT00716820
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2015-10
- **Final completion:** 2016-09
- **Target enrollment:** 472 (ACTUAL)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00716820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00716820, "Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00716820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*